Outlook Pharmaceuticals, Inc.

The US Food and Drug Administration is paying close attention to sponsored links for prescription drug products, issuing its third enforcement letter in the past 18 months objecting to a link on Googl

The US Food and Drug Administration’s Office of Prescription Drug Promotion issued six enforcement letters in 2020, just one more than the record low set in 2017. While citations declined they focused

The US Food and Drug Administration reprimanded Sprout Pharmaceuticals, Inc. for a radio advertisement for Addyi (flibanserin) that fails to disclose the risk of taking the hypoactive sexual desire

The US Food and Drug Administration criticized Xeris Pharmaceuticals, Inc. 's Gvoke PFS (glucagon pre-filled syringe) television advertisement for leaving out serious risks associated with the diabet